[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"plantar-fasciitis-of-both-feet\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:plantar-fasciitis-of-both-feet":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,46,81,107,128],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100637756","video-based-versus-physician-led-exercise-training-for-plantar-fasciitis-100637756",false,"NCT07628218","Video-Based Versus Physician-Led Exercise Training for Plantar Fasciitis","Clinical Effectiveness of Video-Based Exercise Training Compared With Physician-Led Face-to-Face Exercise Instruction in Patients With Plantar Fasciitis: A Randomized Non-Inferiority Trial","Inclusion Criteria:\n\n* Adults aged 18 to 70 years\n* Clinical diagnosis of plantar fasciitis\n* Plantar heel pain lasting for at least 3 months\n* Heel pain that is most prominent with the first steps in the morning or after rest\n* Tenderness on palpation of the medial calcaneal tubercle\n* Baseline heel pain score of 4 or higher on a 0-10 numerical rating scale\n* Functional capacity to perform the prescribed exercises\n* Access to a smartphone, tablet, or computer to view the exercise video\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Previous foot or ankle surgery on the affected side\n* History of foot fracture, foot tumor, advanced neuropathy, Charcot arthropathy, or tarsal tunnel syndrome\n* Corticosteroid injection, extracorporeal shock wave therapy, platelet-rich plasma injection, or other interventional treatment for plantar fasciitis within the last 6 months\n* Inflammatory arthritis or systemic rheumatologic disease affecting the foot\n* Severe knee or hip osteoarthritis limiting exercise performance\n* Severe cognitive impairment preventing participation or completion of questionnaires\n* Pregnancy\n* Inability or unwillingness to comply with the study protocol","ALL","18 Years","70 Years",{"count":20,"type":21},300,"ESTIMATED","INTERVENTIONAL",[24],"NA","This prospective, single-center, two-arm, parallel-group randomized non-inferiority trial will compare physician-led face-to-face exercise instruction with standardized video-based exercise instruction in adults with plantar fasciitis. Participants will be randomized in a 1:1 ratio to receive either face-to-face exercise training by an orthopedic physician or access to a standardized exercise video via QR code\u002Fweb link. The exercise content will be identical in both groups; only the method of instruction will differ. The primary outcome will be the change in the Foot Function Index total\u002Findex score from baseline to 3 months. Secondary outcomes will include pain score, Foot Function Index subscales, exercise knowledge, exercise adherence, education time, video viewing status, additional treatment requirement, and patient satisfaction.",[27,28],"Plantar Fasciitis of Both Feet","Plantar Fascitis",[30,31,32],"Exercise Therapy","Patient Education","Non-Inferiority Trial","RECRUITING","2026-06-03",{"date":36,"type":37},"2026-06-04","ACTUAL",{"date":39,"type":37},"2026-02-12",{"date":41,"type":21},"2026-08-12",{"name":43,"class":44},"Balikesir Ataturk City Hospital","OTHER_GOV",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":67,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":45},"100610737","platelet-rich-plasma-for-musculoskeletal-conditions-100610737","NCT07231471","Platelet Rich Plasma for Musculoskeletal Conditions","PRP for MSK","Inclusion Criteria:\n\n* 18+ years old\n* Musculoskeletal pathology that may benefit from a PRP injection\n* Failed other conservative treatments\n\nExclusion Criteria:\n\n* No active malignancy\n* No active infection in the area of injection\n* No platelet disorder\n* No active systemic infections\n* No patients currently undergoing dialysis",true,{"count":55,"type":21},10000,[24],"The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction.\n\nThis will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.",[59,60,61,62,63,64,65,27,66],"Osteoarthritis (OA)","Osteoarthritis (OA) of the Knee","Osteoarthritis (OA) of the Hip","Osteoarthritis (OA) of the Shoulder","Osteoarthritis Ankle","Elbow Osteoarthritis","Epicondylitis of the Elbow","Tendinopathy",[68,69,70,66],"PRP","Platelet Rich Plasma","Osteoarthritis","2026-05-05",{"date":73,"type":37},"2026-05-06",{"date":75,"type":37},"2025-12-29",{"date":77,"type":21},"2035-01-01",{"name":79,"class":80},"University of Utah","OTHER",{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":85,"acronym":86,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":88,"enrollmentInfo":89,"targetDuration":4,"studyType":22,"phases":91,"briefSummary":92,"conditions":93,"keywords":94,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":45},"100574107","temporal-differences-in-pain-muscle-stiffness-and-function-in-subjects-with-plantar-fasciitis-after-myofascial-release-therapy-100574107","NCT06754982","Temporal Differences in Pain, Muscle Stiffness, and Function in Subjects With Plantar Fasciitis After Myofascial Release Therapy","TDPSFPFMR","Inclusion Criteria:\n\n* Study participants must be diagnosed with PF\n* Age between 18 to 60 years a clinical diagnosis of unilateral PF according to the clinical practice guidelines of the orthopedic section of the American Physical Therapy Association (APTA).\n* Pain intensity \\> 2 on the numerical pain rating scale (NPRS).\n* Pain that is most intense upon awakening and decreases during walking. • Duration of pain greater than 3 months and less than 7 months.\n* Both sexes.\n\nExclusion Criteria:\n\n* Who have received ankle or foot interventions within the previous three months, such as physical therapy (manual therapy, exercise, physical agents), injections, long-term history of steroid use.\n* History of surgery on the ankle, foot, or inner leg.\n* Other causes of heel pain: arthritic (fibromyalgia, gout, rheumatoid arthritis, seronegative spondyloarthropathies), infectious (diabetic ulcers, osteomyelitis, plantar warts), neurological (lumbar radiculopathy (L4-S2), nerve entrapment (branches of posterior tibial nerve), neuroma, tarsal tunnel syndrome, (posterior tibial nerve), trauma (calcaneal stress fracture), tumor (Ewing's sarcoma, neuroma), vascular and pregnancy.","60 Years",{"count":90,"type":21},50,[24],"Plantar fasciitis (PF) is a common condition in the population. One of the interventions used to resolve this condition is myofascial release (MR), which consists of massages that help reduce pain and increase mobility. MR has shown efficacy when applied for 30 minutes, however, it is necessary to compare it with a 15-minute MR intervention, since in clinical practice optimizing time is essential. Accordingly, the present research seeks to evaluate whether there are differences in the application time of myofascial release in people with PF.",[27],[95,96,97],"Plantar fasciitis","Myofascial release","manual therapy","2025-03-24",{"date":100,"type":37},"2025-03-27",{"date":102,"type":37},"2025-01-31",{"date":104,"type":21},"2027-01-31",{"name":106,"class":80},"Universidad Católica del Maule",{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":16,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":22,"phases":117,"briefSummary":118,"conditions":119,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":45},"100578026","embolization-for-the-treatment-of-heel-pain-secondary-to-plantar-fasciitis-100578026","NCT06805942","Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis","Inclusion Criteria:Participants aged 22 years or older. Diagnosed with plantar fasciitis by an orthopedic or podiatry surgeon.\n\nUltrasound evaluation showing:\n\nIncreased plantar fascia thickness \\> 4 mm. Hyperemia in the plantar fascia near its proximal insertion or perifascial soft tissue.\n\nSelf-reported pain of at least 5\u002F10 on the Visual Analog Scale (VAS). Negative X-ray for acute fractures. Refractory to at least 6 weeks of conservative therapies. Able to provide written informed consent. -\n\nExclusion Criteria:Heel pain caused by stress fractures, nerve entrapment, or inflammatory conditions such as arthritis, gout, or bursitis.\n\nCorticosteroid injection in the plantar fascia within 90 days prior to embolization.\n\nPrior surgical repair or plantar fascia rupture. Severe allergy to Lipiodol or iodinated contrast media. Diagnosis of peripheral arterial disease affecting the lower extremities. Active workers' compensation claim for plantar fasciitis. Pregnancy or breastfeeding. Type 1 Diabetes Mellitus or significant renal dysfunction (GFR \\\u003C 45 or serum creatinine \\> 2.0 mg\u002FdL).\n\nSensory or motor neuropathy of the feet. Active skin wounds on the plantar surface of the affected foot.\n\n\\-","22 Years","100 Years",{"count":116,"type":21},10,[24],"This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.",[27],{"date":121,"type":37},"2025-02-03",{"date":123,"type":21},"2025-02-15",{"date":125,"type":21},"2025-09-30",{"name":127,"class":80},"IR Centers",{"id":129,"slug":130,"hasResults":11,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":134,"eligibilityCriteria":135,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":22,"phases":139,"briefSummary":140,"conditions":141,"keywords":143,"overallStatus":150,"whyStopped":4,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":154,"completionDateStruct":156,"leadSponsor":158,"locationsCount":45},"100567671","effectiveness-of-infiltrations-in-the-treatment-of-plantar-fasciopathy-100567671","NCT06671223","Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy","Effectiveness of Infiltrations in the Treatment of Plantar Fasciopathy: A Randomized Clinical Study.","INFILTRA-PLANT","Inclusion Criteria:\n\nAge: Participants aged 18 to 50 years. Diagnosis: Confirmed diagnosis of plantar fasciopathy based on clinical evaluation and imaging (if applicable).\n\nDuration of Symptoms: Symptoms persisting for at least 6 weeks prior to enrollment.\n\nPain Level: Reported pain level of at least 4 on the Visual Analog Scale (VAS) at baseline.\n\nAbility to Comply: Participants must be able to follow study protocols and attend follow-up appointments.\n\nInformed Consent: Participants must provide written informed consent to participate in the study.\n\nExclusion Criteria:\n\nOther Foot Pathologies: Presence of other significant foot conditions (e.g., fractures, arthritis, tarsal tunnel syndrome) that could interfere with the study results.\n\nPregnancy or Breastfeeding: Pregnant or breastfeeding individuals will be excluded from the study.\n\nNeurological Disorders: History of significant neurological disorders affecting lower limb function.\n\nSystemic Conditions: Patients with systemic conditions (e.g., diabetes, autoimmune diseases) that could affect healing or response to treatment.\n\nAllergy to Corticosteroids: Known allergy or adverse reaction to corticosteroids or local anesthetics.\n\nPsychiatric Disorders: Individuals with severe psychiatric disorders that may impair their ability to provide informed consent or adhere to the study protocol.","50 Years",{"count":138,"type":21},200,[24],"This clinical study aims to evaluate the effectiveness of infiltrations in the treatment of plantar fasciopathy, a painful condition that affects the sole of the foot and is common in active people. Plantar fasciopathy is caused by inflammation or damage to the plantar fascia, the tissue that connects the heel to the toes. Participants in this study will be randomly assigned to receive one of two treatments: corticosteroid infiltrations or conservative treatment without infiltrations. Infiltrations will be guided by ultrasound to ensure accuracy. The study will evaluate pain reduction and improvement in foot function over a six-month period. The objective of the study is to determine if infiltrations provide a significant improvement compared to other non-invasive treatments. The results will help doctors and patients make informed decisions about the best treatment options for plantar fasciopathy.",[27,142],"Plantar Fasciopathy",[144,145,146,68,147,148,149],"plantar fasciitis","fasciopaty","corticosteroid","hyaluronic acid","infiltrations","treatment","NOT_YET_RECRUITING","2024-10-31",{"date":153,"type":37},"2024-11-04",{"date":155,"type":21},"2025-06-01",{"date":157,"type":21},"2026-12-01",{"name":159,"class":80},"University of Seville"]